Peptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.
Collagen Tripeptide F (CTP-F)
Overview
Collagen Tripeptide F is a synthetic tripeptide designed to mimic fragments of native collagen that appear during tissue remodeling. It is hypothesized to bind to fibroblast surface receptors and promote extracellular matrix deposition, thereby accelerating wound healing and connective tissue repair.
Mechanism of Action
The tripeptide structure is intended to enhance bioavailability compared to larger collagen molecules.
Research Summary & Key Findings
Preclinical studies in cell culture and animal wound models have suggested enhanced collagen synthesis and fibroblast proliferation. Clinical trial data in humans remain limited, and peer-reviewed publications documenting efficacy in controlled settings are sparse.
Clinical Status
Collagen Tripeptide F (CTP-F) is in the research phase with limited clinical data in humans. Current evidence is primarily derived from preclinical (animal or in vitro) studies.
Administration Routes
References
Primary literature
- PubMed: "Collagen Tripeptide F"
Peer-reviewed literature indexed by the National Library of Medicine.
- ClinicalTrials.gov: "Collagen Tripeptide F"
Registered interventional and observational studies, including status and phase.
- PubChem: "Collagen Tripeptide F"
Chemical structure, molecular properties, and bioactivity data.
Study-level citations for this compound are being verified against the primary sources before publication. The database queries above return the current indexed literature in the meantime.
Related Peptides in Recovery
BPC-157
Research PhaseA synthetic gastric pentadecapeptide derived from a protein found in human gastric juice. BPC-157 promotes angiogenesis ...
View detailsTB-500 (Thymosin Beta-4)
In Clinical TrialsThymosin Beta-4 is a 43-amino acid actin-sequestering protein involved in cell migration, differentiation, and tissue re...
View detailsGHK-Cu
Research PhaseA naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine) found in human plasma, saliva, and urine. G...
View detailsDSIP (Delta Sleep-Inducing Peptide)
Research PhaseA naturally occurring nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) originally isolated from cerebral venous blood o...
View detailsNo lawful pathway today
Collagen Tripeptide F (CTP-F) is not FDA-approved and does not currently have a lawful prescription or compounding pathway in the United States, so there is nothing for us to sell you here and no consultation to book. That can change: eight peptides moved back to a lawful pathway in February 2026.
Tell me if the status changes
One email, only if this compound's regulatory standing actually moves. Not a newsletter, not a sales sequence.
Join the Association
Access exclusive peptide protocols, provider resources, and community support.
List Your PracticeDisclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol. See our editorial policy for how this content is produced and reviewed.